Cytek Biosciences, Inc. CTKB Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$18.87M-65.5% | -$44.08M— | -$5.48M-682% | -$5.58M+46.5% | -$11.4M-84.8% | ||
| $1.87M-0.5% | $1.9M+2.3% | $1.92M+3.6% | $1.89M+4.5% | $1.88M+10.4% | ||
| $4.86M-26.7% | $5.53M-21.1% | $5.64M-20.1% | $6.79M-5.1% | $6.63M+17.6% | ||
| -$2.74M-2,089% | -$771K-139% | -$3.9M-129% | $0-100% | -$125K-103% | ||
| $2.17M+155% | $1M+12.0% | $657K-35.0% | $1.58M+49.8% | $849K+49.7% | ||
| -$27.08M-386% | —— | $18.92M+220% | -$16.41M— | $9.45M+264% | ||
| $0-100% | —— | —— | $4.51M+68.9% | $10.63M— | ||
| $5.07M+634% | $1.42M-49.2% | $2.09M+41,720% | $1.39M— | $690K-50.5% | ||
| $869K-42.8% | $2.94M+2,015% | $145K+3.6% | $142K+2.2% | $1.52M+992% | ||
| $3.98M+134% | -$1.23M+66.3% | —— | -$2.6M-52.1% | -$11.55M-816% | ||
| -$25.19M-631% | -$2.43M+96.2% | —— | -$19.83M-326% | -$3.45M-328% | ||
| -$4.9M-403% | -$1.77M-261% | -$4.56M-137% | -$1.47M-129% | -$974K-129% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Cytek Biosciences, Inc. generate?
- Cytek Biosciences, Inc. (CTKB) generated -$7.4M in operating cash flow over the trailing twelve months.
- What is Cytek Biosciences, Inc.'s free cash flow?
- After $5.4M of capital expenditures, Cytek Biosciences, Inc.'s free cash flow was -$12.7M over the trailing twelve months, down 172.6% year over year.
- Where does Cytek Biosciences, Inc.'s cash flow data come from?
- Every line is extracted from Cytek Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
